Keefe Bruyette lowered the firm’s price target on Bain Capital Specialty Finance (BCSF) to $16 from $17 and keeps a Market Perform rating on the shares. Credit quality remains good, but a non-accrual loan held in the joint venture drove most of the net asset value decline, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCSF:
- Bain Capital Specialty Finance price target lowered to $15 from $16 at Wells Fargo
- Bain Capital Specialty Finance Reports Strong Q3 Earnings
- Bain Capital Specialty Finance: Mixed Sentiment in Q3 Earnings Call
- Bain Capital Specialty Finance Announces Q3 Results and Dividend
- Is BCSF a Buy, Before Earnings?
